The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
Titel:
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
Auteur:
Eiermann, W. Rezai, M. Kümmel, S. Kühn, T. Warm, M. Friedrichs, K. Schneeweiss, A. Markmann, S. Eggemann, H. Hilfrich, J. Jackisch, C. Witzel, I. Eidtmann, H. Bachinger, A. Hell, S. Blohmer, J.